Salgia R - Search Results

1

Gemcitabine and vinorelbine in patients with advanced lung cancer: preclinical studies and report of a phase I trial.

Herbst RS, Lynch C, Vasconcelles M, Teicher BA, Strauss G, Elias A, Anderson I, Zacarola P, Dang NH, Leong T, Salgia R, Skarin AT. Herbst RS, et al. Among authors: salgia r. Cancer Chemother Pharmacol. 2001 Aug;48(2):151-9. doi: 10.1007/s002800100282. Cancer Chemother Pharmacol. 2001. PMID: 11561781 Clinical Trial.

2

Changes in Tc-99m radionuclide bone scan images and peripheralization of marrow hematopoietic activity associated with the administration of granulocyte colony stimulating factor as an adjunct to dose-intensified chemotherapy for breast cancer. A case report.

Salgia R, Demetri GD, Kaplan WD. Salgia R, et al. Cancer. 1994 Oct 1;74(7):1887-90. doi: 10.1002/1097-0142(19941001)74:7<1887::aid-cncr2820740710>3.0.co;2-6. Cancer. 1994. PMID: 7521785

3

Molecular abnormalities in lung cancer.

Salgia R, Skarin AT. Salgia R, et al. J Clin Oncol. 1998 Mar;16(3):1207-17. doi: 10.1200/JCO.1998.16.3.1207. J Clin Oncol. 1998. PMID: 9508209 Review.

4

Cancer-associated retinopathy in a patient with non-small-cell lung carcinoma.

Salgia R, Hedges TR, Rizk M, Reimer RH, Skarin AT. Salgia R, et al. Lung Cancer. 1998 Nov;22(2):149-52. doi: 10.1016/s0169-5002(98)00062-2. Lung Cancer. 1998. PMID: 10022222

5

Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571.

Wang WL, Healy ME, Sattler M, Verma S, Lin J, Maulik G, Stiles CD, Griffin JD, Johnson BE, Salgia R. Wang WL, et al. Among authors: salgia r. Oncogene. 2000 Jul 20;19(31):3521-8. doi: 10.1038/sj.onc.1203698. Oncogene. 2000. PMID: 10918610

6

Use of cytokeratins 7 and 20 in determining the origin of metastatic carcinoma of unknown primary, with special emphasis on lung cancer.

Rubin BP, Skarin AT, Pisick E, Rizk M, Salgia R. Rubin BP, et al. Among authors: salgia r. Eur J Cancer Prev. 2001 Feb;10(1):77-82. doi: 10.1097/00008469-200102000-00009. Eur J Cancer Prev. 2001. PMID: 11263595

7

Role of serum tumor markers CA 125 and CEA in non-small cell lung cancer.

Salgia R, Harpole D, Herndon JE 2nd, Pisick E, Elias A, Skarin AT. Salgia R, et al. Anticancer Res. 2001 Mar-Apr;21(2B):1241-6. Anticancer Res. 2001. PMID: 11396194

8

Modulation of the c-Met/hepatocyte growth factor pathway in small cell lung cancer.

Maulik G, Kijima T, Ma PC, Ghosh SK, Lin J, Shapiro GI, Schaefer E, Tibaldi E, Johnson BE, Salgia R. Maulik G, et al. Among authors: salgia r. Clin Cancer Res. 2002 Feb;8(2):620-7. Clin Cancer Res. 2002. PMID: 11839685

9

Inhibition of epidermal growth factor receptor signaling in malignant pleural mesothelioma.

Jänne PA, Taffaro ML, Salgia R, Johnson BE. Jänne PA, et al. Among authors: salgia r. Cancer Res. 2002 Sep 15;62(18):5242-7. Cancer Res. 2002. PMID: 12234991

10

Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-Kit in small cell lung cancer cells.

Kijima T, Maulik G, Ma PC, Tibaldi EV, Turner RE, Rollins B, Sattler M, Johnson BE, Salgia R. Kijima T, et al. Among authors: salgia r. Cancer Res. 2002 Nov 1;62(21):6304-11. Cancer Res. 2002. PMID: 12414661

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

599 results

Search Page

Filters